Currently there are two vaccines already authorized from FDA and EMA for Emergency Use (1). They are the BNT162b2 and the mRNA‐1273, respectively produced by Pfizer/BioNTech® and Moderna® (Tab.1). Both vaccines consist of nucleic acid, mRNA able to induce our human cells to use protein factories to make the antigen (viral spike protein) that will trigger an immune response.
VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should now / Diotallevi, F; Campanati, A; Radi, G; Martina, E; Rizzetto, G; Barbadoro, P; D’Errico, Mm; Offidani, A. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 1468-3083. - ELETTRONICO. - (2021). [10.1111/jdv.17256]